EA201990513A1 - АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ - Google Patents
АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙInfo
- Publication number
- EA201990513A1 EA201990513A1 EA201990513A EA201990513A EA201990513A1 EA 201990513 A1 EA201990513 A1 EA 201990513A1 EA 201990513 A EA201990513 A EA 201990513A EA 201990513 A EA201990513 A EA 201990513A EA 201990513 A1 EA201990513 A1 EA 201990513A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- bone diseases
- pparγ agonist
- pparγ
- agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
Способы лечения поражения костей, включая остеопороз или его симптомы, с использованием агонистов PPARγ и, в частности, соединения формулы (I), известного как INT131
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662376732P | 2016-08-18 | 2016-08-18 | |
PCT/US2017/047584 WO2018035449A1 (en) | 2016-08-18 | 2017-08-18 | Pparϒ agonist for treatment of bone disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201990513A1 true EA201990513A1 (ru) | 2019-08-30 |
Family
ID=61197122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201990513A EA201990513A1 (ru) | 2016-08-18 | 2017-08-18 | АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПОРАЖЕНИЙ КОСТЕЙ |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190167660A1 (ru) |
EP (1) | EP3500269A4 (ru) |
JP (2) | JP2019524889A (ru) |
KR (1) | KR20190065252A (ru) |
CN (1) | CN109843292A (ru) |
AU (1) | AU2017313842A1 (ru) |
BR (1) | BR112019003133A2 (ru) |
CA (1) | CA3033971A1 (ru) |
EA (1) | EA201990513A1 (ru) |
SG (2) | SG11201901328VA (ru) |
WO (1) | WO2018035449A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220070057A (ko) | 2015-03-09 | 2022-05-27 | 인테크린 테라퓨틱스, 아이엔씨. | 비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법 |
EP3606527A1 (en) | 2017-04-03 | 2020-02-12 | Coherus Biosciences, Inc. | Ppar-gamma agonist for treatment of progressive supranuclear palsy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0301146A3 (en) * | 2000-04-28 | 2004-08-30 | Sankyo Co | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use |
US7223761B2 (en) * | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
EP1722789A2 (en) * | 2004-03-08 | 2006-11-22 | Amgen Inc. | Therapeutic modulation of ppar (gamma) activity |
EA201792096A3 (ru) * | 2013-01-30 | 2018-05-31 | Интекрин Терапьютикс, Инк. | РАППγ АГОНИСТЫ ДЛЯ ЛЕЧЕНИЯ РАССЕЯННОГО СКЛЕРОЗА |
EP3203999B1 (en) * | 2014-10-10 | 2020-01-08 | Liminal Biosciences Limited | Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis |
-
2017
- 2017-08-18 SG SG11201901328VA patent/SG11201901328VA/en unknown
- 2017-08-18 AU AU2017313842A patent/AU2017313842A1/en not_active Abandoned
- 2017-08-18 KR KR1020197007605A patent/KR20190065252A/ko not_active Application Discontinuation
- 2017-08-18 WO PCT/US2017/047584 patent/WO2018035449A1/en unknown
- 2017-08-18 BR BR112019003133-2A patent/BR112019003133A2/pt not_active IP Right Cessation
- 2017-08-18 CN CN201780063392.8A patent/CN109843292A/zh active Pending
- 2017-08-18 US US16/326,070 patent/US20190167660A1/en not_active Abandoned
- 2017-08-18 EP EP17842205.1A patent/EP3500269A4/en not_active Withdrawn
- 2017-08-18 CA CA3033971A patent/CA3033971A1/en active Pending
- 2017-08-18 EA EA201990513A patent/EA201990513A1/ru unknown
- 2017-08-18 JP JP2019530368A patent/JP2019524889A/ja active Pending
- 2017-08-18 SG SG10202101500WA patent/SG10202101500WA/en unknown
-
2022
- 2022-06-03 JP JP2022090843A patent/JP2022116294A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2017313842A1 (en) | 2019-03-07 |
US20190167660A1 (en) | 2019-06-06 |
BR112019003133A2 (pt) | 2019-05-21 |
JP2022116294A (ja) | 2022-08-09 |
KR20190065252A (ko) | 2019-06-11 |
JP2019524889A (ja) | 2019-09-05 |
CN109843292A (zh) | 2019-06-04 |
EP3500269A1 (en) | 2019-06-26 |
CA3033971A1 (en) | 2018-02-22 |
SG10202101500WA (en) | 2021-03-30 |
SG11201901328VA (en) | 2019-03-28 |
WO2018035449A1 (en) | 2018-02-22 |
EP3500269A4 (en) | 2020-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019550050A1 (en) | Isoxazole analogs as fxr agonists and methods of use thereof | |
CU20210029A7 (es) | Inhibidores de proteína tirosina fosfatasa shp2 útiles en el tratamiento de enfermedades | |
EA201890308A1 (ru) | Замещенные азасоединения как ингибиторы irak-4 | |
EA201800367A1 (ru) | Способы лечения болезни хантингтона | |
EA201791018A1 (ru) | Производные 6-амино-7-бицикло-7-деазапурина в качестве ингибиторов протеинкиназы | |
EA201790078A1 (ru) | Ингибиторы mnk и связанные с ними способы | |
EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
EA201691135A1 (ru) | Новые ингибиторы глутаминазы | |
EA201692079A1 (ru) | Ингибиторы лизин-специфической деметилазы-1 | |
MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
EA201691516A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
MY195437A (en) | Methods of Treatment for Cholestatic and Fibrotic Diseases | |
CR20200362A (es) | CICLOPROPILAMINA COMO INHIBIDORES DE LA LSD1 (Divisional 2016-0395) | |
EA201591382A1 (ru) | Ингибиторы гистондеметилаз | |
EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
EA201400735A1 (ru) | Производные альфа-амино бороновой кислоты, селективные ингибиторы иммунопротеасомы | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201791095A1 (ru) | Способ лечения рака | |
EA201692480A1 (ru) | Фармацевтическая композиция | |
BR112016015236A2 (pt) | inibidores de serina/treonina quinase | |
EA201890567A1 (ru) | Способ лечения рака | |
EA201791451A1 (ru) | 5-[(пиперазин-1-ил)-3-оксо-пропил]-имидазолидин-2,4-дионовые производные в качестве ингибиторов adamts для лечения остеоартрита | |
EA202091676A1 (ru) | Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину | |
BR112017006420A2 (pt) | derivados de ácido borônico | |
BR112015006037A2 (pt) | métodos para tratamento de hcv |